Ypeginterferon Alfa-2b

pegylated interferon alfa-2b · Xiamen Amoytop Biotech Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Ypeginterferon Alfa-2b, covering 2013-02-04 to 2013-02-04. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Ypeginterferon Alfa-2b in HBeAg Positive Chronic Hepatitis B [Phase 2]